Blue Jet Healthcare Limited has scheduled an earnings call to discuss its audited standalone financial results for the quarter and financial year ended March 31, 2026. The conference call is set to take place on Monday, May 25, 2026, at 4:00 PM IST. The company operates as a specialty pharmaceutical and healthcare ingredient and intermediate company under a contract development and manufacturing organisation (CDMO) business model.

Earnings Call Details

The earnings call will be accessible to participants across multiple geographies through universal access numbers as well as international toll-free lines. Participants are requested to dial in 10 minutes before the scheduled start time. The following table summarises the key details of the earnings call:

Management Representatives

The earnings call will feature participation from the following senior management members of Blue Jet Healthcare:

• Mr. Shiven Arora — Managing Director
• Mr. V.K. Singh — Chief Operating Officer
• Mr. Ganesh Karuppanan — Chief Financial Officer
• Mr. Sanjay Sinha — Deputy Chief Financial Officer

About Blue Jet Healthcare

Blue Jet Healthcare has developed specialised chemistry capabilities in contrast media intermediates and high-intensity sweeteners. It supplies a critical starting intermediate and several advanced intermediates to three of the largest contrast media manufacturers in the world, including GE Healthcare, Guerbet, and Bracco. The company also supplies high-intensity sweeteners to several multinational companies, including Colgate Palmolive (India) Limited and Unilever, and has built a long-term customer base with innovator and multinational generic pharmaceutical companies, supported by multi-year contracts.

Blue Jet Healthcare Limited has filed its quarterly compliance certificate with the stock exchanges for the quarter ended March 31, 2026. The pharmaceutical company submitted the mandatory documentation to both BSE Limited and the National Stock Exchange of India Limited on April 08, 2026.

Regulatory Compliance Details

The compliance certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. MUFG Intime India Private Limited, formerly known as Link Intime India Pvt. Ltd., serves as the company's Registrar and Share Transfer Agent and issued the certificate on April 02, 2026.

Share Holding Status

The certificate confirms that Regulation 74(5) is not applicable to Blue Jet Healthcare Limited, as the entire holding of the company's shares remains in demat form. MUFG Intime India Private Limited reported that no requests were received from any members of the company for rematerialisation during the quarter ended March 31, 2026.

Corporate Information

Blue Jet Healthcare Limited operates from its registered and corporate office located at 701 & 702, Bhumiraj Costarica, Plot 1 & 2, Sector - 18, Sanpada, Navi Mumbai - 400705. The company maintains three manufacturing units across Maharashtra, including facilities in Shahad, Ambernath, and Mahad.

Filing Authority

The compliance certificate was signed by Sweta Poddar, Company Secretary and Compliance Officer (Membership No.: F12287), on behalf of Blue Jet Healthcare Limited. The digital signature was applied on April 08, 2026, at 11:41:41 +05'30'.

This quarterly filing represents part of the company's ongoing regulatory compliance obligations with the Securities and Exchange Board of India and demonstrates the complete digitisation of its shareholding structure.